Analysis of point-of-care and over-the-counter testing methods for hemoglobin A1c: How good do they need to be?

Journal of Diabetes Science and Technology

Volumn 4, Issue 6, 2010, Pages 1504-1506

  Little, Randie R ^a  

^a University of Missouri   (United States)

Author keywords

Accuracy; Diabetes; Glycated hemoglobin; HbA1c; Precision

Indexed keywords

BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ANALYTICAL EQUIPMENT; ATTITUDE TO HEALTH; BLOOD; BLOOD SAMPLING; DIABETES MELLITUS; EQUIPMENT DESIGN; HOSPITAL INFORMATION SYSTEM; HUMAN; NOTE; PATIENT EDUCATION; PATIENT SATISFACTION; PREDICTIVE VALUE; REPRODUCIBILITY; STANDARD;

BIOLOGICAL MARKERS; BLOOD SPECIMEN COLLECTION; DIABETES MELLITUS; EQUIPMENT DESIGN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 79953007355     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400626     Document Type: Article

References (11)

1. International Diabetes Federation. IDF Diabetes Atlas. The Global Burden of Diabetes. Available from: http://www.diabetesatlas.org/gsearch/ worldwide%2Bprevalence. Accessed August 2010.
2. American Diabetes Association. Tests of glycemia in diabetes (position statement). Diabetes Care 2004;27 Suppl 1:S91-3.
3. American Diabetes Association. Standards of Medical Care in Diabetes 2010. Diabetes Care. 2010;33 Suppl 1:S11-61.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-53.
6. American Association of Clinical Endocrinologists. Medical Guidelines for clinical practice for the Management of Diabetes Mellitus. Endocr Pract. 2007;13(Suppl 1):16.
7. National Institute for Health and Clinical Excellence (NICE). Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes. Available from: http://www.nice.org.uk/nicemedia/live/12165/44318/44318.pdf. Accessed September 2010.
8. NGSP. NGSP Protocol. Available from: http://www.ngsp.org/docs/Protocol. pdf. Accessed August 2010.
9. College of American Pathologists (CAP) GH2 Survey Data. Available from: http://www.ngsp.org/CAP/CAP10a.pdf.
10. Chang A, Frank J, Knaebel J, Fullam J, Pardo S, Simmons D. Evaluation of an over-the-counter glycated hemoglobin (A1C) test. J Diabetes Sci Technol. 2010;4(6):1495-1503.
11. Roberts WL, Safar-Pour S, De BK, Rohlfing CL, Weykamp CW, Little RR. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem. 2005;51:776-8.